Introduction to Biologic and Biosimilar Product Development and Analysis

  • Karen M.┬áNagel

Part of the AAPS Introductions in the Pharmaceutical Sciences book series (AAPSINSTR)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Karen M. Nagel
    Pages 1-29
  3. Karen M. Nagel
    Pages 31-54
  4. Karen M. Nagel
    Pages 55-86
  5. Back Matter
    Pages 99-109

About this book


The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery.   In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.


recombinant DNA technology Therapeutic Proteins Therapeutic antibodies Biologics analysis biologics regualtion

Authors and affiliations

  • Karen M.┬áNagel
    • 1
  1. 1.Chicago College of PharmacyMidwestern UniversityDowners GroveUSA

Bibliographic information

  • DOI
  • Copyright Information American Association of Pharmaceutical Scientists 2018
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-319-98427-8
  • Online ISBN 978-3-319-98428-5
  • Series Print ISSN 2522-834X
  • Series Online ISSN 2522-8358
  • Buy this book on publisher's site